20948762

Source:http://linkedlifedata.com/resource/pubmed/id/20948762

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0079164, umls-concept:C0279492, umls-concept:C0376358, umls-concept:C0392360, umls-concept:C0686907
pubmed:dateCreated	2010-10-15
pubmed:abstractText	Androgen deprivation therapy (ADT) has been the mainstay of palliative treatment in advanced and metastatic prostate cancer for many years. It is also increasingly being used in patients with localized disease. Here we review some recent trials that are providing information on its benefits and disadvantages in different circumstances.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101506841
pubmed:status	PubMed-not-MEDLINE
pubmed:issn	1757-5931
pubmed:author	pubmed-author:KarlAlexanderA, pubmed-author:KonetyBadrinathB
pubmed:issnType	Electronic
pubmed:volume	1
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:year	2009
pubmed:articleTitle	Androgen deprivation therapy for prostate cancer: indications, contraindications and possible consequences.
pubmed:affiliation	Department of Urology, School of Medicine, University of California-San Francisco 1600 Divisadero Street, San Francisco, CA 94143 USA.
pubmed:publicationType	Journal Article